Discovery cohort for genomic predictor of response and survival following neoadjuvant taxane-anthracycline chemotherapy in breast cancer
Homo sapiens
224 Downloadable Samples
Affymetrix Human Genome U133A Array (hgu133a)
Submitter Supplied Information
Description
PURPOSE: To develop a predictive test for response and survival following neoadjuvant taxane-anthracycline chemotherapy for HER2-negative invasive breast cancer.